Elizabeth Parrish: the conversation
Mornings in the Lab · Center Stage · Interview transcript
Transcribed from the recorded guest conversation. Automatic transcription may contain errors. Timestamps refer to the source recording or segment.
[00:01:27] ↗[00:01:27] Keith Bilous: Johnny, that's where I eggs the conversation. And you can have it with her because I'm not into that one. Not for cosmetic reasons, not because she was sick, but because she decided that aging itself is a disease and she was gonna be the Guinea pig to prove it. Sophia, let's bring her up. Elizabeth Parish into the lab with Keith and John.
[00:01:46] ↗[00:01:46] Liz Parrish: How's it thing? Good morning from Seattle.
[00:01:48] ↗[00:01:48] Keith Bilous: How are you today?
[00:01:49] ↗[00:01:49] Liz Parrish: Good. Good, good, good.
[00:01:51] ↗[00:01:51] Keith Bilous: So hold on. You get on the airplane, you don't tell the husband and kids you're going to Columbia to get some needles stabbed in your body. i I don't care about anything else other than How did that conversation go when you got home?
[00:02:03] ↗[00:02:03] Liz Parrish: Well, I guess that's a, that's a funny part of the conversation. Well, when I got home, I, I was
[00:02:08] ↗[00:02:08] Keith Bilous: Sure. Can you, I'm sorry, Liz, can you jack your audio a little bit? Do you mind?
[00:02:10] ↗[00:02:10] Liz Parrish: Yeah, yeah, yeah.
[00:02:11] ↗[00:02:11] Keith Bilous: Thank you. Just a little louder. It'd be helpful.
[00:02:17] ↗[00:02:17] Liz Parrish: That. Is that better Now?
[00:02:18] ↗[00:02:18] Keith Bilous: That's better. Thank you. Yes, thank you. Awesome.
[00:02:21] ↗[00:02:21] Liz Parrish: So, actually it went really well for me for about eight months because I decided not to bring it up because I needed to recover. Oh. And I needed to, let the gene therapies work and, I kept meaning to tell the family, but I really needed the things to go normally because it was a first experiment in the world.
[00:02:38] ↗[00:02:38] Liz Parrish: And with these gene therapies, in this combination. And, eight months later, my, my husband read it in Wired magazine, and that's when we decided to have the conversation. Are
[00:02:49] ↗[00:02:49] Keith Bilous: you still married?
[00:02:51] ↗[00:02:51] Liz Parrish: Yeah, I am. He is. He is a pretty patient guy.
[00:02:57] ↗[00:02:57] Jon Andersen: So what was the biggest, when what, like, you, you, before the therapy, it was, you were here after you're here, describe,
[00:03:05] ↗[00:03:05] Liz Parrish: yeah. Well, so the, the big, the big exciting gene therapy was telomerase, reverse transcriptase and what it big name, but what it does is lengthens the telomeres at the caps of the ends of the chromosome, therefore extending lifespan and health span.
[00:03:21] ↗[00:03:21] Liz Parrish: So short telomeres are associated with all the diseases of aging. And when your cells can no longer divide, it's because these caps get too short. And then what,
[00:03:31] ↗[00:03:31] Jon Andersen: so can I, can I jump in real quick? Just correct me if I'm wrong here, but tell here. Basically, I'm just trying to make this real simple for our audience, and if I'm wrong, please correct me.
[00:03:39] ↗[00:03:39] Jon Andersen: Basically, it's like a strand of DNA and is it as it, the ends fray and it gets shorter or shorter, it gets down to the point where it's just a nub and you're pretty much just done.
[00:03:48] ↗[00:03:48] Liz Parrish: Yeah, you're pretty much done. They can stay short for a while. It's called cellular senescence, but it's why we look and feel old and it's why we get the end stage diseases, that we then die of and things like cancer.
[00:04:01] ↗[00:04:01] Liz Parrish: when those, those tips get short and frayed, as you explained, it creates genomic instability. I was just reading this morning, a paper came out in molecular biology that showed that if they turned up the expression of telomerase, this is the gene therapy I did temporarily in skin cells, they're resistant to radiation.
[00:04:23] ↗[00:04:23] Liz Parrish: And, this is what we would expect for this therapy for the future. So not only could it extend healthy lifespan, it might make us radiation resistant for space.
[00:04:34] ↗[00:04:34] Jon Andersen: There's a, there's actually a peptide that I've used multiple occasions and it's, it's called epical. It's all about the telomeres and helping.
[00:04:43] ↗[00:04:43] Jon Andersen: The, the argument is can it really lengthen them or is it just slowing it down either way? I, when, when I take the stuff, I take it before bed and the best way I can describe is. I take this stuff, I gotta take it shortly before I go to bed because it's like, when it, when I do feel it kind of set in, it's like my body is just like saying, whoa, thank you.
[00:05:09] ↗[00:05:09] Jon Andersen: Lay down, relax. Let me do what I'm gonna do for a while.
[00:05:13] ↗[00:05:13] Liz Parrish: Yeah. So that was,
[00:05:15] ↗[00:05:15] Keith Bilous: Liz hang. So let's, so just what, we're having a hard time hearing you. Can you get closer to your microphone, like our audience? We're, we're all having a hard time hearing you.
[00:05:21] ↗[00:05:21] Liz Parrish: I haven't had that happen before. I'm not sure. let me check my computer and see what, system it's using for the microphone.
[00:05:28] ↗[00:05:28] Keith Bilous: Yeah, you sound, you sound really far away.
[00:05:30] ↗[00:05:30] Liz Parrish: Yeah, that's the first time I've had that happen. Let me
[00:05:32] ↗[00:05:32] Keith Bilous: and I,
[00:05:33] ↗[00:05:33] Jon Andersen: and check my microphone coming in. So let me do the same thing.
[00:05:37] ↗[00:05:37] Keith Bilous: Johnny, you're okay here. I just got, we got, we got, we just got some comments from the community here. Make
[00:05:40] ↗[00:05:40] Jon Andersen: our guests feel better. Dude, let me say what I'm doing.
[00:05:45] ↗[00:05:45] Keith Bilous: Thanks, Anderson. Yeah, that's good. So we got Liz. Liz. Don't call me Cheryl. Paris. Joe, us this morning we're getting our audio. So around here, I'm really intrigued by this. And Johnny, what? Well, Shirley's getting that sorted out. John Telomeres. So help me as a, as a super layman, you know, I, I, I, you guys both kinda lost me there.
[00:06:03] ↗[00:06:03] Keith Bilous: So what's the telomere?
[00:06:04] ↗[00:06:04] Jon Andersen: So think of a tel. You ever see the diagram where you got the DNA strand? It's got all the circles. Yeah, yeah, yeah, yeah,
[00:06:09] ↗[00:06:09] Keith Bilous: yeah, yeah, yeah, yeah.
[00:06:10] ↗[00:06:10] Jon Andersen: So imagine that. Now imagine the ends are supposed to be kind of like. Protected, let's say, you know? Okay.
[00:06:16] ↗[00:06:16] Keith Bilous: Okay.
[00:06:17] ↗[00:06:17] Jon Andersen: But then just like a shoelace, that little protected part.
[00:06:20] ↗[00:06:20] Jon Andersen: Oh, yeah,
[00:06:20] ↗[00:06:20] Keith Bilous: yeah.
[00:06:21] ↗[00:06:21] Jon Andersen: It kind of, yeah, that part comes off. And now you're left with this frayed tip, and that lace just keeps getting shorter and shorter.
[00:06:28] ↗[00:06:28] Keith Bilous: Oh. And so why, okay, so why does the telomere start working itself back, John? Is that just, is that just our, is our bo is that our body agent?
[00:06:35] ↗[00:06:35] Jon Andersen: Well, I mean, there, I mean, granted, the, the way we live our lives, we fuck ourselves up almost from the jump, the way we eat, the lack of sleep.
[00:06:42] ↗[00:06:42] Jon Andersen: If someone, oh, like if you lived a, a certain style of life, your telomeres, I believe would be far less damaged than if you lived a very different, stressful, non-healthy, non sleeping terrible. Oh. So we, we do it to ourselves.
[00:06:58] ↗[00:06:58] Keith Bilous: So then, Cheryl, you're saying you went for therapy. I think you sound better there, Cheryl.
[00:07:02] ↗[00:07:02] Keith Bilous: Well, you said when you went for therapy, the, the, it extends the life of those telomeres. Am I understanding you correctly?
[00:07:07] ↗[00:07:07] Liz Parrish: Yeah. I'm not Cheryl, I'm Liz, but yeah, I know. I'm joking with you. This is,
[00:07:12] ↗[00:07:12] Keith Bilous: to see if you're listening to me better
[00:07:14] ↗[00:07:14] Liz Parrish: now.
[00:07:15] ↗[00:07:15] Keith Bilous: Keep going. So, but that's what you're saying, Liz. Liz, was that, is that the, the choices we make fray those telomeres.
[00:07:23] ↗[00:07:23] Keith Bilous: You went down for therapy to extend them or to extend the life? Is that how it works?
[00:07:27] ↗[00:07:27] Liz Parrish: Yeah, it, to extend them, so, oh, of several species, the lifespan is actually tied to the length of the telomeres. So that would be dogs, horses, cats, humans, and, and a few other species like sheep. Oh. So when those telomeres get short, basically end stage diseases set in.
[00:07:46] ↗[00:07:46] Liz Parrish: And so the, the goal was to lengthen them. So when, before we did the gene therapy, actually I did try the epitol on for, a couple months, we decided to test that. How much were you doing
[00:07:59] ↗[00:07:59] Jon Andersen: per, per day?
[00:08:00] ↗[00:08:00] Liz Parrish: I don't remember. This was so many years ago. my telomeres were the length of a 60-year-old when I went to get the gene therapy.
[00:08:09] ↗[00:08:09] Liz Parrish: And so that definitely for me wasn't working. about two months after the gene therapy, they were lengthened by 20 years and they continue to lengthen. I redid the gene therapy in 2020 and they lengthened, significantly again. And then they, they have a slow rise of lengthening.
[00:08:26] ↗[00:08:26] Keith Bilous: So, Liz, hold on. Dude, you got me fascinated here.
[00:08:29] ↗[00:08:29] Keith Bilous: So you go through this therapy and you actually can see your telomeres growing again.
[00:08:33] ↗[00:08:33] Liz Parrish: Yeah. Yeah. So we do, multiple testing. We use three different labs. And in the T lymphocytes, that's what's most, used to look at telomere lengthening. Yeah. So it's not every cell in my body that we test, but in the T lymphocytes we see definitive lengthening after the gene therapy and then a slow rise over the years after it.
[00:08:53] ↗[00:08:53] Keith Bilous: Wow. So then John, this, this relates to the peptide therapy. You, you go through my, am I correct in, in, in saying that, John?
[00:09:00] ↗[00:09:00] Jon Andersen: Yeah. I mean epi talent, she mentioned, Liz had mentioned that she had tried that. Yes. And, you know, ultimately in the, in the peptide world is the big question. Does it just slow it or does it actually regrow it?
[00:09:11] ↗[00:09:11] Jon Andersen: Obviously it's, nobody really knows or the, you know, it's inconclusive, so you can argue what you will, but, you know, as, as I lead with all of my research with peptides and everything else I've done with my body, it's, I lead with how I feel. So there's no question there was a positive benefit. What that positive benefit was, I don't know.
[00:09:30] ↗[00:09:30] Jon Andersen: But I know that I, the first time I did it, I did five milligrams a day, which is, I always start on the lower side. I think the, the medical field, was. Advising 10. And I knew some people that did 10, but I thought, God, that just sounds like a lot. So I did the first whole thing at basically half speed, which is pretty much what I'll do sometimes even less than that.
[00:09:51] ↗[00:09:51] Jon Andersen: This last time I did it at 10, I was like, holy shit. There's a fucking big difference there. So whether my telomeres are just being, you know, rejuvenated or, or helped in some way, or lengthened, I'll never know because it's just, it's not, the, you know, the peptide worlds a little different than what, what, Liz is talking about here.
[00:10:14] ↗[00:10:14] Jon Andersen: But there's no question I know for sure that I'm gonna be doing the epi far more often than I originally thought, based upon how it makes me feel
[00:10:24] ↗[00:10:24] Keith Bilous: interesting. Liz, what, what, when you hear John talk about, so we talk about feelings often we, we, we both believe that nu numbers are a guide, but numbers can also be wrong.
[00:10:32] ↗[00:10:32] Keith Bilous: Numbers can be distracting, numbers can be a major distraction. They can be nothing but noise and not a signal. Liz, you know, you said that over a hundred thousand people die every day of aging diseases. And that not knowing there could be a cure and not not acting on it, that itself is what's truly brave.
[00:10:50] ↗[00:10:50] Keith Bilous: Brave. So do you, Liz, ever wrestle with the possibility that your research could be wrong?
[00:10:57] ↗[00:10:57] Liz Parrish: I mean, we, we have to look at a lot of data. So feelings are one thing, but feelings, you know, I mean, when you, when you are part of something experimental, you might feel great about it. You might feel worried about it.
[00:11:07] ↗[00:11:07] Liz Parrish: There might be a lot of feelings around it, but numbers are really important and data is really important in our world. And so it's what we hang our hat on every day. so we want you to feel better, of course, and perform better, but the numbers are important. So if you're looking at metabolic, lemme sneak
[00:11:24] ↗[00:11:24] Jon Andersen: in real quick, right there.
[00:11:25] ↗[00:11:25] Jon Andersen: I, in this case, Keith, I have got say I am 100000% behind what Liz is saying about numbers because we're not talking about the average person getting fucking distracted by a watch on their wrist. We're talking about high level people that need a fucking bitty little metric to understand what they're doing.
[00:11:45] ↗[00:11:45] Jon Andersen: Yeah. Totally different. Yeah. Yeah. And when I, when I chew on numbers, I'm talking about listen, all you idiots out there to stop fucking counting shit, that doesn't matter.
[00:11:54] ↗[00:11:54] Liz Parrish: Yeah,
[00:11:54] ↗[00:11:54] Jon Andersen: yeah. They're, they're, they're specifically using these numbers to diagnose these micro changes, which could turn into 10 years of life.
[00:12:03] ↗[00:12:03] Liz Parrish: Yeah. Yeah. So when, when, when we look at like metabolic markers, those are going to change and they're gonna change hourly in your body. So there are some things that you might test regularly that Yeah. You know, they're going to, change all day long. And so, you know, measuring them is, is kind of like always a, a, a moving target.
[00:12:22] ↗[00:12:22] Liz Parrish: Okay. But some of the markers that we cha we actually check are long-term markers of beneficial health, and those are important. So we have to check the fast moving ones and the slow moving ones and, and that's how we will know how therapies work. So data is king in our world, but also, you know, the optimum of, of a, of what a person feels after a gene therapy is highly important because we want their lifestyle to be, impacted by the therapy itself.
[00:12:50] ↗[00:12:50] Liz Parrish: So if someone who is younger takes a therapy, we probably won't see big movement. But when someone is diseased taking the therapy, we should see the needle move a lot with gene therapy. Yeah.
[00:13:02] ↗[00:13:02] Jon Andersen: Yeah. Quick question. So I know I kind of asked this before, but I'm be more specific. What's the number one thing you felt or you feel from getting this done?
[00:13:12] ↗[00:13:12] Liz Parrish: Yeah. Well, I mean the, the number one thing, and there are probably people out there that, that would resonate with this, is just the lack of limitation, the lack of aches and pains, the lack of ability to do the things that, that I did when I was younger. You know, carrying your groceries, being able to, to run farther, to be able to lift more without, as much pain the next day.
[00:13:36] ↗[00:13:36] Jon Andersen: I remember you're, you're 100% talking my language. This is why I, I do nothing but fucking experiment with ways to do this within, I mean, as an athlete it was, it was high level, it was pd, obviously. And as I'm in my fifties, I'm not competitive anymore, but now it's with, you know, every other different with amino acids to, to peptides.
[00:13:58] ↗[00:13:58] Jon Andersen: So the next question I have is, basically I guess the question, what comes out, just put bluntly, is, is, what did this fucking thing cost? Is it something that, that anybody can do?
[00:14:09] ↗[00:14:09] Liz Parrish: right now the, the therapies are quite cost prohibitive. we work with licensing partners that work outside the US and therefore we are able to, deliver gene therapies at a fraction of the cost of US costs.
[00:14:22] ↗[00:14:22] Liz Parrish: So let's talk about Yeah, totally. Like
[00:14:24] ↗[00:14:24] Jon Andersen: if you're a stem cell, I, I would be going to fucking Columbia.
[00:14:27] ↗[00:14:27] Liz Parrish: Yeah. Well, US approved gene therapies run from two to $7 million. And so when you go offshore, it's, it's less expensive, but it's still pretty cost prohibitive. So there are, licensing partners that do what's called a buyer's club.
[00:14:43] ↗[00:14:43] Liz Parrish: That's probably something we shouldn't talk about, but it's when a lot of people get together and decide to do a gene therapy together and it drives the cost down. So you're still talking about with a single person paying hundreds of thousands, but multiple people paying much less. And it is experimental medicine.
[00:15:00] ↗[00:15:00] Liz Parrish: So I'm not promoting you doing that if there's a clinical Well, I took
[00:15:04] ↗[00:15:04] Jon Andersen: 100% loud and clear, but you're talking to a guy that is already in this world
[00:15:09] ↗[00:15:09] Liz Parrish: Yeah.
[00:15:10] ↗[00:15:10] Jon Andersen: That you're talking about, you know, 'cause like stem cell is something that I keep, I keep kind of toying with that, but this is like a whole nother step beyond stem cell.
[00:15:20] ↗[00:15:20] Liz Parrish: Yeah. I mean, if I was a stem cell person, I think that for you, I would choose exosomes instead. then you don't have to have cell markers in your body that are not your cells. Yeah. I am working with a company now. This is pretty exciting. They're taking your own. Stem cells outta your body. They're genetically modifying them, making them
[00:15:39] ↗[00:15:39] Jon Andersen: beyond This is, this is exactly my concern is that you're gonna put all these fucking things in me.
[00:15:43] ↗[00:15:43] Jon Andersen: Are you really getting 'em from where they're supposed to be coming from? If they're coming from me, yeah, they
[00:15:47] ↗[00:15:47] Liz Parrish: should, they really should be coming from you.
[00:15:48] ↗[00:15:48] Jon Andersen: Yeah. Yeah. They're coming from, yeah. Next thing you know, it's coming from coming. I'm, I'm gonna turn in somebody else because really it's someone else's shit running through me.
[00:15:56] ↗[00:15:56] Liz Parrish: Well, I mean, if it's like an umbilical cord thing, it's not supposed to be, but the thing is, those cells are not gonna stay in your body because your body doesn't recognize them as your own cells. So what is the benefit of a stem cell? It's the exosomes that it's putting off. If it's not your stem cell, you're only really having it injected so that it will send off these protein markers that tell your body to regenerate.
[00:16:19] ↗[00:16:19] Liz Parrish: But you could just take exosomes. they, they're not, they don't stay in your body for very long. You get 'em once a week and then they help regenerate your body. I only tried, exosomes once recently, but it was pretty neat. I'm, I'm not sure, what the benefit was of it, just doing it once, but I would just suggest the, just putting the, the cell markers in there, the proteins that the stem cells would, send off.
[00:16:43] ↗[00:16:43] Liz Parrish: Otherwise, have your, stem cells rejuvenated, reset to a young biological age and put back in your body that then they will implant and they will start regenerating your body long term.
[00:16:55] ↗[00:16:55] Jon Andersen: Yeah, I mean, I, I definitely haven't heard all this. Thank you for that information. But what you're talking about is a whole different platform of, of basically therapeutic possibility for living longer and happier.
[00:17:08] ↗[00:17:08] Liz Parrish: Yeah. And these are, you know, I mean, a lot of people look at this technology and say, you know, is this playing God? I mean, they don't really take into their mind what open heart surgery is. It's, it's, you know, if we can start to just buy an IV injection, infuse you with genes that keep you from having to have your chest opened up and veins moved around your body, or pig heart valves put in your body, you know, this is, this is really beautiful medicine.
[00:17:37] ↗[00:17:37] Keith Bilous: Wow. We're hanging out with Liz. Well, you
[00:17:39] ↗[00:17:39] Jon Andersen: know what the resistance is because this is the shit that fucking, it shuts down. This would be like a replacement of our current system. The subscription model would be over.
[00:17:49] ↗[00:17:49] Liz Parrish: It, it would because the gene therapies will last in your body for, you know, 10 to 15 years before the protein expression goes down.
[00:17:57] ↗[00:17:57] Liz Parrish: So this is more of a set it and forget it and get back to your lifestyle.
[00:18:01] ↗[00:18:01] Jon Andersen: Yeah. Think about how many fucking months of prescriptions of X, y, z big pharma will be losing out on. If people started getting this, she had within a reasonable price, her insurance covered it, you know.
[00:18:12] ↗[00:18:12] Liz Parrish: Well, and think about it, you know, United States is the most prescribed, country in the world, and we have the shortest lifespan of all the industrialized countries.
[00:18:21] ↗[00:18:21] Liz Parrish: So there use something wrong percent.
[00:18:24] ↗[00:18:24] Jon Andersen: We we're 5% of the population. We use 80% of the pills.
[00:18:27] ↗[00:18:27] Keith Bilous: Yeah. Yeah. Liz Parris joining myself and John Anderson this morning. Our mornings in the lab with Keith, John, and friends. She's the CEO and founder of Bio Viva Science, known as Patient Zero, the first human being in history to undergrown gene therapy, specifically to reverse biological aging.
[00:18:43] ↗[00:18:43] Keith Bilous: Liz. So you are, I'm looking here. You look, what do you, you are. 55. Am I correct? Yep.
[00:18:49] ↗[00:18:49] Liz Parrish: I'm 55.
[00:18:50] ↗[00:18:50] Keith Bilous: Biological age is what today.
[00:18:52] ↗[00:18:52] Liz Parrish: You know, it depends on the marker. Okay. So with the, the telomeres, it's really young. It's in the twenties. with the epigenetic age, it's probably like 33 now. And, there are other markers of aging there.
[00:19:04] ↗[00:19:04] Liz Parrish: my, the biological mar markers of aging are, are not my favorite. Okay. I think that the future human is going to register very differently than how we mark aging today. so, you know, I, we continue what, what the future human probably looks like is a lot of upregulation of regeneration. basically that, that is faster, than the degeneration over time, low inflammation markers.
[00:19:32] ↗[00:19:32] Liz Parrish: We definitely show that across patients very low CRP values and, and just a better metabolic, stable meta metabolic,process. So, you know, metabolism is something we definitely need to affect to make people live healthier longer.
[00:19:49] ↗[00:19:49] Keith Bilous: Liz, Johnny, before, before I, before I, I, I, I, I get you back up here, Liz.
[00:19:54] ↗[00:19:54] Keith Bilous: I, I, I gotta ask the tough question again and you know, that's, that's what I'm paid the big bucks to ask. Sure. Listen, critics would say that you're running. An operation for the mega rich people to get on the airplanes, to fly off to international waters, to go and reach into their deep pockets, to chase the unproven, eternal youth.
[00:20:15] ↗[00:20:15] Keith Bilous: What do, what do you say as the founder of a, of, of your successful company, what do you say to that straight up to, to, to that critic who's who asked that question?
[00:20:24] ↗[00:20:24] Jon Andersen: Can I say something real quick? Just before you, just before you say something, Liz, you know, these are the same people that have that fucking bitch about everything else in the world.
[00:20:32] ↗[00:20:32] Jon Andersen: They can't have.
[00:20:35] ↗[00:20:35] Preston and Sterling: Liz?
[00:20:36] ↗[00:20:36] Liz Parrish: Well, I mean, I would say that the, the, the therapies are expensive, but I would also remind people that they're already because of us, one eighth of the price that they would ever be. Otherwise, we are driving those costs down. I'm working with, several companies to make more affordable gene therapies so that everyone can access them.
[00:20:56] ↗[00:20:56] Liz Parrish: And we're the only company in the world, not only to offer these therapies, but to get nonprofits behind us and get people treated for free. Yeah. So we do try to meet the unmet need of people who could not o otherwise afford these therapies. So a new nonprofit just went online. I don't have the name of it right in front of me.
[00:21:18] ↗[00:21:18] Liz Parrish: It's like the Global Health Foundation, and it actually asks for donations. And we've done this in the past with other nonprofits to get people treated who desperately need these therapies and for free, for absolute free. So, I mean, I am here to create affordable therapies for the world. We will do it, but we have to do it by scale and we need funding to do,
[00:21:40] ↗[00:21:40] Jon Andersen: but you know, it's wonderful.
[00:21:41] ↗[00:21:41] Jon Andersen: But remember that person that's bitching. That means they have to get their fat asses off the couch, put the Cheetos down, and actually fill out a form on the internet, which will never happen. All they'll do is sit there and bitch. I
[00:21:53] ↗[00:21:53] Liz Parrish: love it. Well, and it is true. We, we definitely live in a, a victimized society, thank you society where people are not, taking advantage of the things that they could do today.
[00:22:02] ↗[00:22:02] Liz Parrish: I mean, look, I've got two exceptional people that are in really great shape in front of me. A lot of people aren't, but, you know, if we had the ability to, to give them maybe, you know, if for a gross obesity pgc one alpha that would, you know, tear through a lot of that fat and upregulate their mitochondrial function, maybe they would feel more like getting off the couch.
[00:22:22] ↗[00:22:22] Liz Parrish: So, you know, I try to be a proponent of, of being as empathetic as possible to, to people who need therapeutic help.
[00:22:29] ↗[00:22:29] Keith Bilous: Yeah. Liz, you're awesome, man. Liz, don't call me Cheryl Parrish. I'm loving this dude. Johnny, I'm loving this man. I'm just, I'm, I'm looking at the clock and I'm like, I'm, I'm itching. I got a million questions and I'm like, I don't know where to go, but I gotta go with this one for you, Johnny.
[00:22:41] ↗[00:22:41] Keith Bilous: I'll love this one. So Liz, someone on Reddit once asked you what your favorite pizza topping was, and right after you just revealed that you were patient zero for the first anti-aging gene therapy in human history, and you said sun dried tomatoes with the smiley face. So here's the big question, Anderson, has your taste in pizza improved since you became biologically 25?
[00:23:05] ↗[00:23:05] Keith Bilous: Again,
[00:23:06] ↗[00:23:06] Jon Andersen: that's, hold on. If somebody who likes fucking pepper on a pizza versus sun dried tomato, look at the rest of his life. Jesus Christ.
[00:23:14] ↗[00:23:14] Keith Bilous: Come on, Liz. What's your answer?
[00:23:17] ↗[00:23:17] Jon Andersen: That's sun dried. Tomatoes on pizza are fucking nails. Come.
[00:23:21] ↗[00:23:21] Keith Bilous: Come on, Andrew. Get outta here's. Done.
[00:23:23] ↗[00:23:23] Liz Parrish: Right. It's still, I would still stick with those.
[00:23:27] ↗[00:23:27] Liz Parrish: I would
[00:23:27] ↗[00:23:27] Keith Bilous: with those. Liz, you're awesome. Hey, so, we got, we got a, we got a question. Anderson from our resident, bullshit Professor Liz, ad like to introduce you to Dr. John Elli. John's, John's one of the hosts here on our, on, on our show here. He, he joins the show on Fridays. Petro is awesome and he's got a question for you.
[00:23:42] ↗[00:23:42] Keith Bilous: and I'd actually encourage you guys to link up on LinkedIn. He's a professor of bullshit over at the University of Ver, I think down in the Carolinas out there. he's a wonderful dude. when might bio Viva be publicly traded?
[00:23:54] ↗[00:23:54] Liz Parrish: Oh my gosh. We have had a, a couple offers recently to, to be part of acquisitions of IPO type companies and companies that are already public and it, it, it's pretty, I'm not sure.
[00:24:07] ↗[00:24:07] Liz Parrish: I'm not sure. I know, I know that people want that.
[00:24:10] ↗[00:24:10] Jon Andersen: Yeah.
[00:24:11] ↗[00:24:11] Liz Parrish: But, also being a private company gives us the ability to do, of course, the things that we do. Yeah. Yeah. And you can move
[00:24:17] ↗[00:24:17] Jon Andersen: a lot better. You when
[00:24:19] ↗[00:24:19] Liz Parrish: you're not answered to
[00:24:20] ↗[00:24:20] Jon Andersen: fucking, to the,
[00:24:22] ↗[00:24:22] Liz Parrish: once we're a public company, we have to really adhere to the strong guidelines of the United States.
[00:24:27] ↗[00:24:27] Liz Parrish: And even though we do adhere to those now, it sort of takes our mobility away. And the reason we, we were able to do the first study in dementia again for free for patients. Yeah. in gene therapy. The reason we were able to treat myself, the reason that we were able to mobilize all these licensing deals were because we were not a publicly.
[00:24:49] ↗[00:24:49] Keith Bilous: Yeah. Yeah. Let's, what's your,I wanna be respectful of your time. I know we're getting close to the top here. Are, do, do you have a little bit of freedom on time or do you got a hard stop?
[00:24:56] ↗[00:24:56] Liz Parrish: You guys, it's only six o'clock in the morning here. I don't schedule anything till 9:00 AM
[00:25:02] ↗[00:25:02] Keith Bilous: Oh, so what you're saying is you got a little extra time for Keith and John.
[00:25:06] ↗[00:25:06] Liz Parrish: I've got a little extra time.
[00:25:10] ↗[00:25:10] Keith Bilous: So lemme ask you this. What is your opinion on the other. Longevity experts out there, like the Peter Atcha and that dude out there from California that's spending a billion dollars to make his body young. And you, we have this whole longevity industry. And I joke with John because you got these 20 year olds and 30 year olds talking about living long.
[00:25:29] ↗[00:25:29] Keith Bilous: I'm like, dude, you haven't even lived anything. So how can you be promoting longevity? So, so as, as somebody who's in the industry talking about a daily, promoting the benefits of it and, and teaching people, you know, how, how, how comfortable are you offering an opinion on all the other people talking about this?
[00:25:47] ↗[00:25:47] Liz Parrish: Well, I mean, I think that, you know, you always have to be careful of influencers because they're basically trying to give you a lot of information, a lot. And, the information in our space does not flow super fast. Research is, is slow. So, I mean, lifestyle is important, you know, I mean, look at you two, lifestyle is important.
[00:26:06] ↗[00:26:06] Liz Parrish: It, it, it's a game changer to middle life, but it comes with diminishing returns as we age. So, we really need to be in the space of gene therapy and bioelectric, signals, you know, the work of Michael Levin. this is, this is the future of extended lifespan and health span. And so, you know, they, they typically talk about diet and exercise.
[00:26:31] ↗[00:26:31] Liz Parrish: That's great. That'll only get you so far. Do not buy, that, that's going to make a, an outlived person. that's just
[00:26:38] ↗[00:26:38] Jon Andersen: the foundation for all this other shit to, to work
[00:26:40] ↗[00:26:40] Liz Parrish: with. It's the foundation. And so, you know, definitely educate yourself in the world of genetics and what's happening in, in our space because, you know, this is where we want to optimize you, and we want to make it so that you are living a, a fulfilled life late, late into years and see if we can actually break the bottleneck of lifespan.
[00:27:00] ↗[00:27:00] Liz Parrish: Why not?
[00:27:02] ↗[00:27:02] Keith Bilous: Wow. Liz, last question.
[00:27:05] ↗[00:27:05] Liz Parrish: Okay.
[00:27:06] ↗[00:27:06] Keith Bilous: And, and I, and I want you to really sit with this one, think is this, this is a pretty big one actually. You've spent the last decade doing some incredible work trying to make sure that ev that nobody trying to make sure that nobody has to die from aging. Yet within your own home, you have a, you have a beautiful son with type one diabetes.
[00:27:25] ↗[00:27:25] Liz Parrish: That's right. That's my inspiration.
[00:27:27] ↗[00:27:27] Keith Bilous: And he's the reason that you started all this. When you look at your son today, Liz, a young man living with the same disease that you sent you down this rabbit hole, do you feel like you're keeping closer to keeping the promise you made to yourself in that hospital room or
[00:27:42] ↗[00:27:42] Liz Parrish: Yeah.
[00:27:42] ↗[00:27:42] Keith Bilous: You find yourselves further away than you'd thought you'd be.
[00:27:45] ↗[00:27:45] Liz Parrish: I, I found it, it took longer. But we are creating in Switzerland, the first pipeline to a patient's own cells putting type one diabetes in remission. And it took all of these years to find the right doctors, the right research centers in the GMP facilities that believed in me.
[00:28:03] ↗[00:28:03] Liz Parrish: So not only are we delivering on that, we have delivered on, compassionate use manufacturing of gene therapies for, for other diseases that actually affect children, making them more affordable, more available. We've worked on a re-dosing,patent that, that we, we've applied for now, we're gonna help these gene therapy companies in the United States treat children more safely with the gene therapies that they have.
[00:28:29] ↗[00:28:29] Liz Parrish: And we're also delivering on creating a longer life for these kids once we get them cured. So my vision has never stopped. It actually took this long to meet the right people and build the right pipelines, have them believe in me, and show me what capacity they had to do this. So, sadly, things take a long time.
[00:28:49] ↗[00:28:49] Liz Parrish: we don't take care of, each other the way that we need to, but we are opening up worlds in which we are going to do that now.
[00:28:58] ↗[00:28:58] Keith Bilous: That's incredible. Johnny.
[00:29:01] ↗[00:29:01] Jon Andersen: I, I think everything you're doing is great. You know, and, I think the, the naysayers, whatever they are, they're just, they're, they're the ones that are complaining and bitching about.
[00:29:10] ↗[00:29:10] Jon Andersen: Everything. So I think just keep doing what you're doing. I love your compassion. But
[00:29:15] ↗[00:29:15] Broll: yeah,
[00:29:15] ↗[00:29:15] Jon Andersen: you know that nothing is gonna, that guy that's, that's doing what he's doing, he's gotta make the choice to take the first step. All the compassion world's not gonna fucking help that. But I think,
[00:29:27] ↗[00:29:27] Liz Parrish: and you know, I think that that's the problem.
[00:29:30] ↗[00:29:30] Liz Parrish: You know, we know now, scientifically skeptics don't live as long. so you know that that's a, that's the sad truth. we, we need, people to share good information. Skeptics shut people down. Because what they tell you is that I don't have to read. I don't have to learn about it. If somebody says, this might not be true, go read a scientific paper.
[00:29:50] ↗[00:29:50] Liz Parrish: It's true. It's evident. We are slowing and reversing aging in animals all the time. We need to do it in humans. Science was made for humans. It was made for people, especially people who are sick. Let's use it and make a better world. And the skeptics can sit to the side because they don't wanna do anything anyway,
[00:30:08] ↗[00:30:08] Jon Andersen: because at the end of the day, what they finally say, oh, it won't work for me.
[00:30:14] ↗[00:30:14] Liz Parrish: Yeah, well, it won't if you don't take it. That's for sure.
[00:30:17] ↗[00:30:17] Jon Andersen: 100%. It'll never work with your stuff in your face with fucking Cheetos.
[00:30:22] ↗[00:30:22] Liz Parrish: That's right. True.
[00:30:27] ↗[00:30:27] Keith Bilous: Hey, Liz, where can folks find you? Connect with you Good times, says in the comments, can we get some free samples? But where can folks find you? Connect with you?
[00:30:34] ↗[00:30:34] Keith Bilous: Engage you. Yeah.
[00:30:34] ↗[00:30:34] Jon Andersen: This, this is not a sample type scenario. Yeah,
[00:30:37] ↗[00:30:37] Keith Bilous: no,
[00:30:37] ↗[00:30:37] Liz Parrish: it's not a sound type scenario. so you can find us all over social media. BioViva science.com is the company We're on Facebook X. You can find, find me. I'm, what is my, I don't know what my, I'm not great at social media, but I'm great at posting papers.
[00:30:52] ↗[00:30:52] Liz Parrish: Just posted one this morning that will change your life. Yeah. so, you know, mostly we do value added. We don't really pump ourselves up too much. We're, we're con constantly in stealth mode. But, we do share what's happening in science and if you wanna read those papers and learn about them, I mean, it's absolutely amazing what's happening day to day.
[00:31:11] ↗[00:31:11] Liz Parrish: We have. Great,
[00:31:11] ↗[00:31:11] Keith Bilous: well, Sarah, no, I, I would love to have you back. I'd like to have you back. I would love to on a more frequent basis. I think what you're doing is incredible work. I, I love the stuff Johnny's doing. John's my human experiment. He's always sharing stuff.
[00:31:21] ↗[00:31:21] Liz Parrish: I mean, look at him. He's the incredible Hulk.
[00:31:23] ↗[00:31:23] Keith Bilous: A hundred percent. You know, that man's 54 years old and,
[00:31:27] ↗[00:31:27] Liz Parrish: that's beautiful.
[00:31:28] ↗[00:31:28] Keith Bilous: I'm gonna be that same age next week. So, we'd love to have you back. We'd love to have these conversations going, but I wanna put something on the screen before you rock and roll outta here. Robert Hershe, one of the Shark Tank guys, drag his den.
[00:31:38] ↗[00:31:38] Keith Bilous: Guys, I found a really wonderful clip and I shared it with my crew yesterday, including my son, and I said, this is my life right now. And Liz, I think when you see this, it's probably, it was, it's probably been your life and I want, I'd like you to comment on this. Let's run this clip there. Okay? Okay.
[00:31:53] ↗[00:31:53] Broll: Unbelievable amount of loneliness that you're gonna face. There are gonna be so many late nights. There are gonna be so many people that don't believe in you. You have to have the ability to believe in yourself and just keep going,
[00:32:08] ↗[00:32:08] Keith Bilous: Liz
[00:32:08] ↗[00:32:08] Liz Parrish: Perish. Absolutely true. It's not true,
[00:32:11] ↗[00:32:11] Keith Bilous: isn't it?
[00:32:12] ↗[00:32:12] Liz Parrish: And sometimes you don't tell your your family for a while.
[00:32:15] ↗[00:32:15] Keith Bilous: Well, so,
[00:32:15] ↗[00:32:15] Liz Parrish: because you don't wanna freak them
[00:32:17] ↗[00:32:17] Keith Bilous: out. I gotta tell you something. Every, Johnny, I think what we have to do is every second Tuesday we have a clinical sexologist on the show. Her name's Brianna Boss. I think we need to have Brianna and Liz and John on the show for one purpose only so it could, Brianna can talk to Liz and all of us about that whole experience of getting on the plane and going to Columbia and not telling her family she's gonna go and make herself younger.
[00:32:37] ↗[00:32:37] Keith Bilous: Because that, I can't imagine how that conversation went when you got back. 'cause it wasn't just a one and done. So there, when you said, my husband's very patient like Liz, I'm telling man that there's a, there's a lot to unpack there, I'm suspecting.
[00:32:50] ↗[00:32:50] Liz Parrish: Yeah, well, I mean, he was pretty upset until I turned and I said to him, you know, what, are we going to show our children, you know, our son has type one diabetes.
[00:32:58] ↗[00:32:58] Liz Parrish: Do we just show him that we give up and we just bake cookies and take insulin? Or do we go do something to change the world? And so that was it. He was sold. And you know, first he. Kind of had it at me for about two minutes and then I turned and I said that and it was over.
[00:33:15] ↗[00:33:15] Keith Bilous: And, and then you said, no. No.
[00:33:17] ↗[00:33:17] Keith Bilous: And you said, and by the way, honey, I'm hot. 'cause now I'm 20 years younger and I'm gonna be hot younger for you. My, my man. So good for you, Liz. You're awesome. You're so inspiring. I love your mission. I love your purpose. And Johnny, I love the fact you got your rear end outta bed to come hang out with us this morning on early morning in Seattle.
[00:33:34] ↗[00:33:34] Keith Bilous: So Liz, thank you for that. Honest to God. Yeah, seriously. Thank
[00:33:36] ↗[00:33:36] Liz Parrish: you for that. Have a great day everyone. Good morning.
[00:33:38] ↗[00:33:38] Keith Bilous: You too. Yes. Good morning. Thank you Liz.